Tirzepatide (Mounjaro) for Weight Loss in Cheshire & Merseyside
The new weight management medication ‘tirzepatide’ (brand name Mounjaro®) is being made available shortly to NHS patients to support weight loss.
NHS Cheshire & Merseyside is currently in the process of establishing new community-based weight management services, which are set to launch this summer. Tirzepatide will NOT be available on prescription for weight loss from GP practices in Southport.
Therefore, please do not request an appointment at The Corner Surgery to discuss tirzepatide in the meantime. We anticipate that eligible patients will be contacted once the new local service is up and running, to see if they would like to be referred.
Availability of tirzepatide is being made available on a phased basis, with the first group of patients eligible under the national criteria being those who:
- Have a Body Mass Index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)
AND
- Have at least FOUR of the following long-term conditions:
1. Type 2 diabetes
2. Hypertension (high blood pressure)
3. Dyslipidaemia
4. Established cardiovascular disease
5. Obstructive sleep apnoea
For more information including frequently access questions, please click here.
We are aware that many patients are choosing to obtain tirzepatide in the private sector, often from online pharmacies. For such patients, if you are taking a hormonal contraception tablet, please read this leaflet.
If you are taking a progestogen tablet as part of your HRT, then tirzepatide may have an impact on the effectiveness of your HRT. This means that your HRT might not protect your endometrium (womb lining) enough. Such patients should contact the surgery to book a HRT review, as we may need to increase your dose or change you to a different form of HRT.